PetMed Express (NASDAQ:PETS) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?

PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $4.05 and traded as high as $5.80. PetMed Express shares last traded at $5.46, with a volume of 310,128 shares trading hands.

Analyst Ratings Changes

Separately, StockNews.com upgraded PetMed Express from a "hold" rating to a "buy" rating in a research note on Tuesday, November 12th.

PetMed Express Price Performance

The company has a market capitalization of $115.28 million, a price-to-earnings ratio of -92.17 and a beta of 0.71. The business has a 50 day simple moving average of $4.68 and a 200 day simple moving average of $4.06.

PetMed Express (NASDAQ:PETS - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.17. The business had revenue of $59.57 million during the quarter, compared to analysts' expectations of $66.02 million. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. On average, equities research analysts predict that PetMed Express, Inc. will post 0.24 EPS for the current year.

Insider Activity

In other news, Director Leslie C.G. Campbell acquired 15,000 shares of the company's stock in a transaction dated Wednesday, December 4th. The stock was acquired at an average cost of $5.38 per share, for a total transaction of $80,700.00. Following the acquisition, the director now directly owns 70,000 shares in the company, valued at approximately $376,600. This represents a 27.27 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 1.10% of the company's stock.

Hedge Funds Weigh In On PetMed Express

Institutional investors and hedge funds have recently bought and sold shares of the stock. Federated Hermes Inc. boosted its position in PetMed Express by 54.5% during the 2nd quarter. Federated Hermes Inc. now owns 606,430 shares of the company's stock valued at $2,456,000 after purchasing an additional 213,903 shares during the period. Cubist Systematic Strategies LLC purchased a new stake in shares of PetMed Express during the second quarter valued at $797,000. Bleakley Financial Group LLC purchased a new stake in shares of PetMed Express in the 3rd quarter valued at approximately $279,000. Squarepoint Ops LLC purchased a new position in PetMed Express during the 2nd quarter valued at about $273,000. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of PetMed Express during the 2nd quarter valued at $135,000. Hedge funds and other institutional investors own 73.33% of the company's stock.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.